AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 18 filers reported holding AZURRX BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,398,000 | +66.4% | 2,924,088 | +171.9% | 0.00% | – |
| Q1 2021 | $1,441,000 | +116.7% | 1,075,484 | +56.8% | 0.00% | – |
| Q4 2020 | $665,000 | +27.6% | 685,922 | -6.3% | 0.00% | – |
| Q3 2020 | $521,000 | -16.4% | 732,132 | +6.5% | 0.00% | – |
| Q2 2020 | $623,000 | +53.8% | 687,164 | -1.6% | 0.00% | – |
| Q1 2020 | $405,000 | -44.2% | 698,538 | 0.0% | 0.00% | – |
| Q4 2019 | $726,000 | +73.3% | 698,538 | 0.0% | 0.00% | – |
| Q3 2019 | $419,000 | -5.4% | 698,538 | +168.4% | 0.00% | – |
| Q2 2019 | $443,000 | +150.3% | 260,306 | +255.0% | 0.00% | – |
| Q1 2019 | $177,000 | +98.9% | 73,321 | 0.0% | 0.00% | – |
| Q4 2018 | $89,000 | -91.6% | 73,321 | -82.3% | 0.00% | – |
| Q3 2018 | $1,063,000 | -18.2% | 413,439 | +2.1% | 0.00% | – |
| Q2 2018 | $1,300,000 | +264.1% | 404,950 | +256.5% | 0.00% | – |
| Q1 2018 | $357,000 | +8.2% | 113,584 | +27.2% | 0.00% | – |
| Q4 2017 | $330,000 | +0.6% | 89,278 | +8.7% | 0.00% | – |
| Q3 2017 | $328,000 | – | 82,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pensionmark Financial Group, LLC | 80,000 | $57,000 | 0.02% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 178,203 | $127,000 | 0.01% |
| Traynor Capital Management, Inc. | 24,999 | $20,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 30,000 | $21,000 | 0.00% |
| Waldron Private Wealth LLC | 69,835 | $49,000 | 0.00% |
| Beacon Pointe Advisors, LLC | 39,363 | $28,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 6,250 | $4,000 | 0.00% |
| BlackRock Inc. | 15,338 | $11,000 | 0.00% |
| Bank of New York Mellon Corp | 215,313 | $153,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 800 | $1,000 | 0.00% |